Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Consensus Rating of “Moderate Buy” by Brokerages

Lantheus Holdings, Inc. (NASDAQ:LNTH) has been assigned a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $78.00.

Several equities research analysts have recently commented on the company. Truist Financial increased their price objective on Lantheus from $80.00 to $82.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Weiss Ratings raised shares of Lantheus from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 6th. Finally, Mizuho increased their price target on shares of Lantheus from $60.00 to $72.00 and gave the company an “outperform” rating in a research note on Wednesday, December 17th.

Institutional Investors Weigh In On Lantheus

Hedge funds have recently bought and sold shares of the stock. Nordea Investment Management AB increased its position in Lantheus by 1.6% during the second quarter. Nordea Investment Management AB now owns 48,075 shares of the medical equipment provider’s stock worth $3,913,000 after acquiring an additional 737 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Lantheus during the 2nd quarter worth $1,812,000. DekaBank Deutsche Girozentrale raised its holdings in Lantheus by 7.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 10,551 shares of the medical equipment provider’s stock valued at $866,000 after acquiring an additional 746 shares in the last quarter. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Lantheus during the 2nd quarter valued at $246,000. Finally, Liberty One Investment Management LLC increased its position in shares of Lantheus by 6.9% in the second quarter. Liberty One Investment Management LLC now owns 10,634 shares of the medical equipment provider’s stock worth $870,000 after purchasing an additional 687 shares during the period. 99.06% of the stock is currently owned by institutional investors and hedge funds.

Lantheus Price Performance

Shares of LNTH opened at $71.27 on Wednesday. The company has a quick ratio of 2.49, a current ratio of 2.67 and a debt-to-equity ratio of 0.51. Lantheus has a twelve month low of $47.25 and a twelve month high of $111.29. The stock has a market capitalization of $4.73 billion, a P/E ratio of 29.95 and a beta of -0.08. The company has a 50 day moving average of $66.65 and a 200-day moving average of $59.38.

About Lantheus

Lantheus Holdings, Inc is a global life sciences company specializing in the development, manufacturing and commercialization of diagnostic imaging agents and radiopharmaceuticals. Headquartered in North Billerica, Massachusetts, Lantheus focuses on products that enhance the detection and management of cardiovascular and oncologic diseases. The company’s portfolio spans ultrasound-enhancing agents, molecular imaging tracers for positron emission tomography (PET), and emerging theranostic platforms designed to pair diagnostic and therapeutic applications.

The diagnostic imaging segment includes ultrasound contrast agents such as DEFINITY® (perflutren lipid microsphere) and Sonazoid® (perflubutane), which improve the visualization of cardiac structures and blood flow.